Reports
Microbiome Drug Database Update: March 2021
You must be logged in to view this content. Please login here or if you do not have an account register here.
Microbiome Times
Pharma & Human Health
Predicting microbial interactions in the human gut
The human gut consists of a complex community of microbes that consume and secrete hundreds of small molecules–a phenomenon called cross-feeding. However, it is challenging to study these processes experimentally. A new study, published in […]
Finance
Ferring, Rebiotix and MyBiotics Collaborate to Develop Microbiome Therapeutics in Reproductive Medicine and Maternal Health
Ferring Pharmaceuticals, Rebiotix Inc., a Ferring Company, and MyBiotics Pharma Ltd. today announced a multi-year strategic collaboration to develop live microbiota-based biotherapeutics to address bacterial vaginosis, a common vaginal infection among women of reproductive age […]
Pharma & Human Health
Smectite promotes probiotic biofilm formation in gut for cancer immunotherapy
Scientists from Nanjing University and the University of Macau have devised a new approach to extend the survival of transplanted probiotics in vivo, enhancing the efficacy of cancer chemo-/immunotherapies in mice. The paper entitled “Smectite […]
Finance
Global biotech executive to boost microbiome drug development for Asia Pacific
Global biotech executive Thomas Mitchell is set to drive growth, innovation and expansion across Asia Pacific for thriving biotechnology start-up BiomeBank, Australia’s first public stool bank and microbiome therapeutics company, bringing with him a wealth […]
Lallemand Health Solutions
Probiotics to Provide Holistic Health Benefits
A healthy mind in a healthy body is a widely used mantra, now even more relevant than ever before. Since 2020, consumers’ behavior has evolved: 64% are now more conscious about their immunity and 43% […]
Editor's Choice
Fecal transplant turns cancer immunotherapy non-responders into responders
Fecal transplant changes the gut microbiome, turning cancer immunotherapy non-responders into responders. Video Credits: UNIVERSITY OF PITTSBURGH Researchers at UPMC Hillman Cancer Center and the National Cancer Institute (NCI) demonstrate that changing the gut […]
Pharma & Human Health
Investigating the removal of dry biofilm with probiotic cleansers
A CONCEPT known as dry biofilms has emerged over the past few years and they have shown to frequently harbour potentially infectious organisms, just like the ones present in Hospital Acquired Infections (HAIs). However, as […]
Pharma & Human Health
MIND and Mediterranean diets associated with later onset of Parkinson’s disease
A new study from UBC researchers suggests a strong correlation between following the MIND and Mediterranean diets and later onset of Parkinson’s disease (PD). While researchers have long known of neuroprotective effects of the MIND […]
Pharma & Human Health
Lactobacillus manipulates bile acids to create favorable gut environment
New research from North Carolina State University reveals that probiotic Lactobacillus bacteria use enzymes situationally to manipulate bile acids and promote their own survival in the gut. These findings further elucidate the complicated relationship between […]
Pharma & Human Health
Da Volterra Receives first Authorizations from Regulatory Authorities in EU Countries to Initiate Phase 3 Clinical Trial Evaluating Microbiome Protector DAV132
Da Volterra, a clinical-stage biopharmaceutical company developing innovative products to prevent the life-threatening effects antibiotics have on the gut microbiome of cancer patients, announced today that it received approval to start enrolling patients in a […]